Pharvaris NV (PHVS)
22.29
+1.25
(+5.94%)
USD |
NASDAQ |
Nov 22, 16:00
22.08
-0.20
(-0.92%)
After-Hours: 20:00
Pharvaris Enterprise Value: 867.99M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 867.99M |
| November 21, 2024 | 800.19M |
| November 20, 2024 | 770.91M |
| November 19, 2024 | 771.45M |
| November 18, 2024 | 793.69M |
| November 15, 2024 | 762.77M |
| November 14, 2024 | 773.62M |
| November 13, 2024 | 745.96M |
| November 12, 2024 | 735.11M |
| November 11, 2024 | 811.58M |
| November 08, 2024 | 885.34M |
| November 07, 2024 | 869.61M |
| November 06, 2024 | 1.015B |
| November 05, 2024 | 917.88M |
| November 04, 2024 | 956.93M |
| November 01, 2024 | 968.86M |
| October 31, 2024 | 1.008B |
| October 30, 2024 | 1.004B |
| October 29, 2024 | 947.17M |
| October 28, 2024 | 925.47M |
| October 25, 2024 | 836.53M |
| October 24, 2024 | 815.92M |
| October 23, 2024 | 863.65M |
| October 22, 2024 | 871.78M |
| October 21, 2024 | 886.97M |
| Date | Value |
|---|---|
| October 18, 2024 | 808.87M |
| October 17, 2024 | 811.58M |
| October 16, 2024 | 825.14M |
| October 15, 2024 | 788.26M |
| October 14, 2024 | 774.16M |
| October 11, 2024 | 729.15M |
| October 10, 2024 | 626.11M |
| October 09, 2024 | 630.44M |
| October 08, 2024 | 629.90M |
| October 07, 2024 | 644.55M |
| October 04, 2024 | 646.17M |
| October 03, 2024 | 629.36M |
| October 02, 2024 | 652.68M |
| October 01, 2024 | 658.65M |
| September 30, 2024 | 663.53M |
| September 27, 2024 | 633.03M |
| September 26, 2024 | 651.93M |
| September 25, 2024 | 645.45M |
| September 24, 2024 | 657.33M |
| September 23, 2024 | 662.19M |
| September 20, 2024 | 685.41M |
| September 19, 2024 | 770.74M |
| September 18, 2024 | 725.92M |
| September 17, 2024 | 725.38M |
| September 16, 2024 | 744.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-127.45M
Minimum
Dec 02 2022
1.294B
Maximum
Dec 29 2023
460.20M
Average
404.72M
Median
Jun 01 2021
Enterprise Value Benchmarks
| uniQure NV | -102.39M |
| ProQR Therapeutics NV | 288.57M |
| Merus NV | 2.482B |
| argenx SE | 33.13B |
| Pharming Group | 434.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -45.87M |
| Total Expenses (Quarterly) | 41.69M |
| EPS Diluted (Quarterly) | -0.8469 |
| Earnings Yield | -12.67% |